Heart failure & cardiomyopathies

The efficacy and safety of qiliqiangxin according to baseline ejection fraction in patients with heart failure and reduced ejection fraction in QUEST

Eur J Heart FailPublished Secondary analysis of the QUEST randomised trial

Authors' conclusion

In patients with HFrEF, lower LVEF was associated with worse cardiovascular outcomes. QLQX reduced cardiovascular events consistently across the range of LVEF examined in QUEST, despite the limited use of sodium-glucose co-transporter 2 inhibitors.

Study context

Population
Patients with symptomatic heart failure (HF) and left ventricular ejection fraction (LVEF) ≤40% (heart failure and reduced ejection fraction (HFrEF))
Participants
3,110 patients
Comparison
QLQX vs control, by baseline LVEF
  • LVEF ≤25%n = 482
  • LVEF >25-30%n = 692
  • LVEF >30-35%n = 829
  • LVEF >35%n = 1,107
Primary endpoint
CV death or first HF hospitalization
Methodological detailspost hoc analysis
  • Post hoc analysis

Primary result

As reported in the abstract

CV death or first HF hospitalization, by baseline LVEF category (subgroup analysis)
QLQXHazard ratio (95% CI)
LVEF ≤25%
0.91(0.64–1.30)
LVEF >25-30%
0.65(0.47–0.89)
LVEF >30-35%
0.94(0.71–1.26)
LVEF >35%
0.71(0.55–0.91)
Effect of QLQX consistent across LVEF categories
P for interaction = 0.28
Effect of QLQX consistent with LVEF as a continuous variable
P for interaction = 0.45

Further findings

Primary outcome rate by baseline LVEF — LVEF ≤25%
25.4 per 100 patient-years
Primary outcome rate by baseline LVEF — Similar rates across higher LVEF groups
18.7-19.8

Primary outcome rate by baseline LVEF

Lower LVEF independently associated with higher risk of primary outcome and mortality after multivariable adjustment

Individual components and total HF hospitalizations, by LVEF

Similar results across LVEF categories
all interaction P > .10

Safety

Safety of QLQX consistent across LVEF categories

Original publication

The efficacy and safety of qiliqiangxin according to baseline ejection fraction in patients with heart failure and reduced ejection fraction in QUEST. Eur J Heart Fail. Published 12 January 2026. doi:10.1093/ejhf/xuaf017

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.